Market Exclusive

Analyst Activity – SunTrust Banks, Inc. Reiterates Buy on Amedisys (NASDAQ:AMED)

Analyst Ratings For Amedisys (NASDAQ:AMED)

Today, SunTrust Banks, Inc. reiterated its Buy rating on Amedisys (NASDAQ:AMED) with a price target of $60.00.

There are 6 hold ratings, 4 buy ratings on the stock.

The current consensus rating on Amedisys (NASDAQ:AMED) is Hold (Score: 2.40) with a consensus target price of $55.90 per share, a potential 14.29% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Amedisys (NASDAQ:AMED)
Amedisys (NASDAQ:AMED) has insider ownership of 2.00% and institutional ownership of 96.55%.

Recent Trading Activity for Amedisys (NASDAQ:AMED)
Shares of Amedisys closed the previous trading session at with shares trading hands.

Exit mobile version